blue triangle graphic

Unlocking IL-2's Potential

blue triangle graphic

Unlocking the Immune System: Investigating a 

Re-engineered Approach to Treat Cancer

This sponsored article, featuring Craig Hopkinson, M.D., Alkermes' Chief Medical Officer, originally appeared in Scrip in December 2021.In November 2023, Alkermes completed the separation of its oncology business into Mural Oncology plc, a new, independent, publicly traded company. Visit to learn more.

Executive Summary

Read the full article